T. Rowe Price Associates’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $105M | Buy |
|
|||||
|
2023
Q3 | $28.4M | Buy |
|
|||||
|
2023
Q2 | $1.03M | Buy |
|
|||||
|
2023
Q1 | $634K | Sell |
|
|||||
|
2022
Q4 | $811K | Sell |
|
|||||
|
2022
Q3 | $613K | Buy |
|
|||||
|
2022
Q2 | $360K | Buy |
|
|||||
|
2022
Q1 | $342K | Buy |
|
|||||
|
2021
Q4 | $327K | Sell |
|
|||||
|
2021
Q3 | $502K | Hold |
|
|||||
|
2021
Q2 | $600K | Buy |
|
|||||
|
2021
Q1 | $315K | Buy |
|
|||||
|
2020
Q4 | $275K | Buy |
|
|||||
|
2020
Q3 | $171K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $4.55M | Sell |
|
|||||
|
2018
Q2 | $9.22M | Sell |
|
|||||
|
2018
Q1 | $9.09M | Buy |
|